https://thomson-walsh.com/2026-09-06T08:27:19.251Z https://thomson-walsh.com/about/ https://thomson-walsh.com/contacts/ https://thomson-walsh.com/authors/ https://thomson-walsh.com/categories/pharmacovigilance/2026-09-06T07:13:01.275Z https://thomson-walsh.com/categories/medical-affairs/2026-09-06T07:15:29.344Z https://thomson-walsh.com/categories/regulatory-compliance/2026-09-06T08:27:19.251Z https://thomson-walsh.com/categories/clinical-development/2026-09-06T05:54:03.328Z https://thomson-walsh.com/categories/medical-consulting/2026-09-05T23:22:16.552Z https://thomson-walsh.com/articles/medical-signatory-review-inside-the/2026-09-06T08:27:19.251Zhttps://thomson-walsh.com/assets/medical-signatory-review-inside-the.webp https://thomson-walsh.com/articles/field-medical-insights-why-qualitative/2026-09-06T07:15:29.344Zhttps://thomson-walsh.com/assets/field-medical-insights-why-qualitative.webp https://thomson-walsh.com/articles/bridging-the-gap-between-ai/2026-09-06T07:13:01.275Zhttps://thomson-walsh.com/assets/bridging-the-gap-between-ai.webp https://thomson-walsh.com/articles/psur-eurd-alignment-practical-steps/2026-09-06T06:33:20.936Zhttps://thomson-walsh.com/assets/psur-eurd-alignment-practical-steps.webp https://thomson-walsh.com/articles/adaptive-vs-fixed-trial-design/2026-09-06T05:54:03.328Zhttps://thomson-walsh.com/assets/adaptive-vs-fixed-trial-design.webp https://thomson-walsh.com/articles/advisory-board-failures-a-medical/2026-09-06T05:09:08.605Zhttps://thomson-walsh.com/assets/advisory-board-failures-a-medical.webp https://thomson-walsh.com/articles/pharmacovigilance-system-master-file/2026-09-06T04:45:59.702Zhttps://thomson-walsh.com/assets/pharmacovigilance-system-master-file.webp https://thomson-walsh.com/articles/eu-regulatory-shift-aims-to/2026-09-05T23:24:16.031Zhttps://thomson-walsh.com/assets/eu-regulatory-shift-aims-to.webp https://thomson-walsh.com/articles/key-regulatory-updates-from-the/2026-09-05T23:22:16.552Zhttps://thomson-walsh.com/assets/key-regulatory-updates-from-the.webp https://thomson-walsh.com/articles/eudravigilance-signal-detection-what/2026-09-04T14:02:00.000Zhttps://thomson-walsh.com/assets/eudravigilance-signal-detection-what.webp https://thomson-walsh.com/articles/fractional-cmo-strategy-actionable-steps/2026-09-03T09:37:00.000Zhttps://thomson-walsh.com/assets/fractional-cmo-strategy-actionable-steps.webp https://thomson-walsh.com/articles/investigator-initiated-studies-internal/2026-09-03T07:42:00.000Zhttps://thomson-walsh.com/assets/investigator-initiated-studies-internal.webp https://thomson-walsh.com/articles/promotional-review-pitfalls-a-pmcpa/2026-08-30T08:26:00.000Zhttps://thomson-walsh.com/assets/promotional-review-pitfalls-a-pmcpa.webp https://thomson-walsh.com/articles/surrogate-endpoints-vs-overall-survival/2026-08-27T07:07:00.000Zhttps://thomson-walsh.com/assets/surrogate-endpoints-vs-overall-survival.webp